Clean Power Hydrogen says hydrolyser damage too severe to repair.


Clean Power Hydrogen said on Friday that it had suspended work on factory acceptance testing for its MFE220 1MW electrolyser after concluding that damage from a recent test-site incident was too severe to repair and that the unit would require substantial redesign.

  • Clean Power Hydrogen
  • 05 June 2026 14:46:05
Clean Power Hydrogen

Source: Sharecast

The AIM-traded green hydrogen technology company said the incident occurred during a standard shutdown procedure in the third and final stage of factory acceptance testing, causing damage to the electrolyser and prompting the suspension of all operations under its health, safety and environmental protection processes.

CPH2 said a subsequent inspection and review of available data showed the damage was significant and that the system could not be repaired to allow testing to continue.

Its insurers were informed immediately and had visited the test site to begin their assessment, while the exact cause of the incident remained under investigation.

The company said its chief technical officer and chief operations director had advised the board that the MFE220 unit would require substantial redesign to ensure the mixed gas system could be operated safely in all conditions.

While the board said it retained confidence in the potential of the technology, it concluded that CPH2 did not currently have the financial, engineering or technical resources needed to undertake such a programme.

As a result, the board decided not to recommence FAT3 activities for the MFE220 electrolyser and would instead pursue alternative, non-manufacturing commercial strategies.

CPH2 said it believed its intellectual property, including six patent families across 12 countries, licensees, copyrights, designs, schematics, commercial relationships and more than a decade of technical knowhow, had significant commercial value.

It said it was now evaluating options to maximise value from those assets, including potential commercial, licensing and strategic alternatives.

The company added that working capital remained constrained and that there was material uncertainty over continuing operations while talks with capital providers continued.

Trading in CPH2’s shares on AIM remained suspended pending further updates.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: -1.36 ( -0.17 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.